Please ensure Javascript is enabled for purposes of website accessibility
ORIGINAL PAPER
The sexuality and disability of males with multiple sclerosis in Poland
 
More details
Hide details
 
Submission date: 2014-03-03
 
 
Acceptance date: 2014-03-04
 
 
Publication date: 2014-04-01
 
 
Medical Studies 2014;30(1):35-38
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: Multiple sclerosis (MS) is one of the most common diseases of the central nervous system. In the world
2.1 mil­lion people suffer from MS. Usually MS is diagnosed between the ages of 20 and 50 years old and may be the cause of disability. Sexual problems are very common in male patients with MS although they are less frequent than they used to be.
Aim of the research study: To describe the level of disability and sexual life in males with MS.
Material and methods: The study was carried out on a total of 72 MS patients. MS subtypes included 30.55% (n = 22) secondary progressive; 27.77% (n = 20) relapsing-remitting; 22.22% (n = 16) primary progressive; and 16.66% (n = 12) progressive relapsing. The research tools consisted of our own questionnaires. Neurological disability was assessed by the Regional Committee for Adjudication of Disability and by the Expanded Disability Status Scale.
Results: 8.33% (n = 6) of patients reported sexual activity every day, most reported either several times a week 25% (n = 18), several times a month 33.33% (n = 24), once a month 16.66% (n = 12), a few times a year 5.55% (n = 4) or once a year 11.11%
(n = 8). Our findings conclude that neurological disability, low sexual activity and frequent use of sildenafil citrate or similar were common in the patients tested.
Conclusions: These problems are permanently overlooked by medical professionals. In this aspect, cooperation between neurologists and sexologists could be important. Further research is needed for better understanding of the sexuality of this particular population.
REFERENCES (30)
1.

Girouard N, Soucy N. Patient considerations in the management of multiple sclerosis: development and clinical utility of oral agents. Patient Prefer Adherence 2011; 5: 101-108.
 
2.

Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol 2011; 9: 409-416.
 
3.

National Multiple Sclerosis Society. Fact sheet: multiplesclerosis http://www.nationalmssociety.o....
 
4.
/me¬diacenter/factsheetmultiplesclerosis/index.aspx. Aces sed 7 May 2013.
 
5.

Tullman MJ. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care 2013; 19: 15-20.
 
6.

Thompson A, Toosy A, Ciccarelli O. Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol 2010; 9: 1182-1199.
 
7.

Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911.
 
8.

de Seze J, Zephir H, Hautecoeur P, et al. Pathologic laughing and intractable hiccups can occur early in multiple sclerosis. Neurology 2006; 67: 1684-1686.
 
9.

Fode M, Krogh-Jespersen S, Brackett NL, et al. Male sexual dysfunction and infertility associated with neurological disorders. Asian J Androl 2012; 14: 61-68.
 
10.

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 2003; 33: 1444-1452.
 
11.

Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard University Press 1996; 1-98.
 
12.

Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989; 112: 133-146.
 
13.

Karampampa K, Gustavsson A, Miltenburger C, et al. Treatment experience, burden, and unmet needs in multiple sclerosis: the costs and utilities of MS patients in Canada. J Popul Ther Clin Pharmacol 2012; 19: e11-e25.
 
14.

Keller JJ, Liang YC, Lin HC. Association between multiple sclerosis and erectile dysfunction: a nationwide case-control study. J Sex Med 2012; 9: 1753-1739.
 
15.

Kessler TM, Fowler CJ, Panicker JN. Sexual dysfunction in multiple sclerosis. Expert Rev Neurother 2009; 9: 341-350.
 
16.

Landtblom AM, Lang C, Flensner G. The study circle as a tool in multiple sclerosis patient education in Sweden. Patient Prefer Adherence 2008; 2: 225-232.
 
17.

Guo ZN, He SY, Zhang HL, et al. Multiple sclerosis and sexual dysfunction. Asian J Androl 2012; 14: 530-535.
 
18.

Szasz G, Paty D, Lawton-Speert S, Eisen K. A Sexual Functioning Scale in multiple sclerosis. Acta Neurol Scand Suppl 1984; 101: 37-43.
 
19.

Reininghaus E, Reininghaus B, Fitz W, et al. Sexual behavior, body image, and partnership in chronic illness: a comparison of Huntington’s disease and multiple sclerosis. J Nerv Ment Dis 2012; 200: 716-720.
 
20.

Foley FW, Sanders A. Sexuality, multiple sclerosis and women. Mult Scler Manag 1997; 1: 1-9.
 
21.

Schmidt EZ, Hofmann P, Niederwieser G, et al. Sexuality in multiple sclerosis. J Neural Transm 2005; 112: 1201-1211.
 
22.

Dupont S. Multiple sclerosis and sexual functioning – a review. Clin Rehabil 1995; 9: 135.
 
23.

Demirkiran M, Sarica Y, Uguz S, et al. Multiple sclerosis patients with and without sexual dysfunction: are there any differences? Mult Scler 2006; 12: 209-214.
 
24.

Khan F, Pallant JF, Ng L, Whishaw M. Sexual dysfunction in multiple sclerosis. Sex Disabil 2011; 29: 101-111.
 
25.

Hatzichristou DG. Sildenafil citrate: lessons learned from 3 years of clinical experience. Int J Impot Res 2002; 1: 43-52.
 
26.

Lindau ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357: 762-774.
 
27.

Celik DB, Poyraz EÇ, Bingöl A, et al. Sexual dysfunction ın multiple sclerosis: gender differences. J Neurol Sci 2013; 324: 17-20.
 
28.

Foley FW, Zemon V, Campagnolo D, et al. The Multiple Sclerosis Intimacy and Sexuality Questionnaire – revali¬-.
 
29.
dation and development of a 15-item version with a large. Mult Scler 2013; 19: 1197-203.
 
30.

Bronner G, Elran E, Golomb J, Korczyn AD. Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention. Acta Neurol Scand 2010; 121: 289-301.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top